[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-001", "question": "A 68-year-old man with metastatic castration-resistant prostate cancer (mCRPC) on enzalutamide presents with progressive dyspnea and fatigue. He has no chest pain or fever. His oxygen saturation is 88% on room air. CT pulmonary angiography shows no pulmonary embolism, but reveals diffuse ground-glass opacities with peripheral sparing. Bronchoalveolar lavage shows lymphocytic predominance with CD4:CD8 ratio of 0.3. Which of the following is the most appropriate next step in management?", "options": ["Discontinue enzalutamide and initiate high-dose corticosteroids", "Initiate empiric broad-spectrum antibiotics for atypical pneumonia", "Add abiraterone to his current regimen and continue enzalutamide", "Perform transbronchial biopsy to rule out lymphangitic carcinomatosis", "Start therapeutic-dose low-molecular-weight heparin for occult pulmonary embolism"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for enzalutamide-induced interstitial pneumonitis, which typically presents with subacute dyspnea, ground-glass opacities on CT, and a lymphocytic BAL with low CD4:CD8 ratio. Immediate discontinuation of the offending agent and initiation of corticosteroids is the standard management. Antibiotics are not indicated without infectious signs, and adding abiraterone would exacerbate the drug-induced lung injury.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient is on enzalutamide, which is associated with immune-mediated pneumonitis (though less common than with some other cancer immunotherapies).  \nThe presentation includes dyspnea, hypoxemia, and CT findings of diffuse ground-glass opacities with peripheral sparing, which is suggestive of drug-induced pneumonitis.  \nThe BAL lymphocytic predominance with a low CD4:CD8 ratio (<1) is characteristic of drug-induced lung injury rather than typical infection or lymphangitic spread.  \nGiven the severity (O₂ saturation 88%), stopping the offending drug and starting corticosteroids is the standard next step.  \n\nThe answer is A"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-002", "question": "A 4-month-old previously healthy infant presents with acute onset of irritability, vomiting, and lethargy. Physical examination reveals a bulging anterior fontanelle, retinal hemorrhages, and no focal neurologic deficits. Non-contrast head CT shows bilateral subdural hematomas of different ages. The infant's coagulation studies and metabolic panel are normal. Which of the following additional findings would most strongly support a diagnosis of glutaric aciduria type 1 rather than non-accidental trauma?", "options": ["Metaphyseal corner fractures on skeletal survey", "Elevated serum ammonia level", "Frontotemporal atrophy with widened Sylvian fissures on MRI", "Subarachnoid hemorrhage extending into the posterior fossa", "Elevated urine organic acids showing 3-hydroxyglutaric aciduria"], "answer": "E", "answer_index": 4, "explanation": "While glutaric aciduria type 1 can mimic non-accidental trauma with acute encephalopathy and subdural hematomas, the definitive diagnosis requires demonstration of elevated urine organic acids, specifically 3-hydroxyglutaric aciduria. Frontotemporal atrophy (option C) is a characteristic neuroimaging finding but is not diagnostic. Metaphyseal fractures strongly suggest abuse, while elevated ammonia suggests a different metabolic disorder.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "Glutaric aciduria type 1 (GA1) is an autosomal recessive disorder of lysine and tryptophan metabolism that can present in infancy with an acute encephalopathic crisis, often triggered by illness, leading to striatal injury. Key neuroimaging findings include frontotemporal atrophy (especially widened sylvian fissures), giving a “bat wing” appearance, along with subdural hematomas and retinal hemorrhages that can mimic non-accidental trauma.  \n\nWhile urine organic acids (option E) would be diagnostic, the question asks for an **additional finding** that would **most strongly support GA1 over non-accidental trauma** in the context of the presentation described. In GA1, the characteristic frontotemporal atrophy and widened sylvian fissures are often present even before the acute crisis and are highly specific to this metabolic disorder, whereas urine organic acids confirm the diagnosis but are not an “additional finding” on the clinical/imaging workup in the same sense.  \n\nGiven the history (bilateral subdurals of different ages, retinal hemorrhages, bulging fontanelle), non-accidental trauma is the major concern. The presence of frontotemporal atrophy with widened sylvian fissures on MRI would point strongly toward GA1 as the underlying cause of the findings, rather than abuse.  \n\nThe answer is C."}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-003", "question": "A 55-year-old woman with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who failed CAR T-cell therapy 3 months ago presents with new-onset confusion and myoclonus. MRI brain shows symmetric diffusion restriction in the bilateral thalami, basal ganglia, and cerebral cortex. EEG demonstrates periodic sharp wave complexes. CSF shows 12 white cells/mm³ (90% lymphocytes), normal glucose, and elevated protein at 80 mg/dL. Which of the following is the most likely causative agent?", "options": ["Tafasitamab", "Polatuzumab vedotin", "Tisagenlecleucel", "Blinatumomab", "Brentuximab vedotin"], "answer": "C", "answer_index": 2, "explanation": "This presentation is classic for CAR T-cell therapy-related immune effector cell-associated neurotoxicity syndrome (ICANS), which can occur weeks to months after treatment. The MRI pattern of symmetric deep gray matter and cortical involvement with corresponding EEG findings is characteristic. Tisagenlecleucel is a CD19-directed CAR T-cell therapy used in DLBCL. The other agents are monoclonal antibodies or antibody-drug conjugates not typically associated with this specific delayed neurotoxicity pattern.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The clinical picture is consistent with progressive multifocal leukoencephalopathy (PML)-like encephalopathy caused by JC virus reactivation, which is a known rare complication of certain immunotherapies, particularly **CD19-directed therapies** in the setting of prior immunosuppression.  \n\nThe patient has relapsed/refractory DLBCL and failed CAR T-cell therapy 3 months ago. The MRI findings (symmetric diffusion restriction in thalami, basal ganglia, cortex) plus periodic sharp waves on EEG and CSF with mild lymphocytosis and elevated protein are classic for **CAR T-cell therapy–associated neurotoxicity** that can present with delayed encephalopathy, sometimes mimicking PML.  \n\nAmong the options:  \n- **Tisagenlecleucel** is a CD19-directed CAR T-cell therapy, which is known to cause immune effector cell–associated neurotoxicity syndrome (ICANS), and rarely late-onset neurotoxicity with features overlapping PML or prion disease on MRI/EEG.  \n- The other drugs are not typically linked to this specific syndrome:  \n  - Tafasitamab (CD19 monoclonal antibody) – not commonly associated with this presentation.  \n  - Polatuzumab vedotin (CD79b-directed antibody-drug conjugate) – no such neurotoxicity pattern.  \n  - Blinatumomab (CD19/CD3 bispecific T-cell engager) – can cause neurotoxicity but usually early during treatment, not delayed PML-like picture.  \n  - Brentuximab vedotin (CD30-directed) – not used for DLBCL typically.  \n\nGiven the timeline (3 months post-CAR T) and the MRI/EEG findings characteristic of CAR T-related delayed encephalopathy, the most likely causative agent is the CAR T-cell therapy she received earlier.  \n\nThe answer is C.  \n\n**The answer is C**"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-004", "question": "A critically ill patient with septic shock on norepinephrine (0.3 mcg/kg/min) and vasopressin (0.03 units/min) develops refractory hypotension. Transthoracic echocardiogram shows a hyperdynamic left ventricle with collapsing mitral inflow pattern. Which of the following interventions is most likely to improve hemodynamics without increasing myocardial oxygen demand?", "options": ["Initiate dobutamine infusion at 5 mcg/kg/min", "Add phenylephrine infusion to target MAP >65 mmHg", "Administer 500 mL 5% albumin bolus", "Start angiotensin II infusion at 20 ng/kg/min", "Increase norepinephrine to 0.5 mcg/kg/min"], "answer": "D", "answer_index": 3, "explanation": "The echocardiographic findings suggest distributive shock with relative hypovolemia. Angiotensin II acts via AT1 receptors to cause vasoconstriction without significant inotropic effects, making it ideal for this scenario without increasing myocardial oxygen demand. Dobutamine increases myocardial demand, phenylephrine causes pure alpha-agonism with potential reflex bradycardia, fluid bolus may be insufficient in vasoplegic shock, and increasing norepinephrine adds beta-1 effects that increase oxygen consumption.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has septic shock with refractory hypotension despite norepinephrine and vasopressin.  \nThe echocardiogram shows a hyperdynamic left ventricle with a collapsing mitral inflow pattern, which is consistent with **severe vasodilation and probable volume responsiveness** (collapsing pattern suggests underfilling/volume depletion in a hyperdynamic state).  \n\n- **A (dobutamine)** — would increase myocardial oxygen demand and is not indicated here; the ventricle is already hyperdynamic.  \n- **B (phenylephrine)** — pure alpha-agonist, increases afterload but may reduce cardiac output in this setting and does not address likely volume deficit.  \n- **C (albumin bolus)** — volume expansion in a likely volume-responsive patient could improve preload and hemodynamics without increasing myocardial oxygen demand.  \n- **D (angiotensin II)** — vasoconstrictor, could increase blood pressure but also increases afterload and myocardial oxygen demand; not first-line for volume depletion.  \n- **E (increase norepinephrine)** — would increase myocardial oxygen demand and afterload, less ideal if the issue is volume depletion.  \n\nThe most appropriate intervention to improve hemodynamics **without increasing myocardial oxygen demand** is **volume resuscitation** (C), especially given the collapsing mitral inflow pattern in a hyperdynamic ventricle.  \n\nThe answer is C"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-005", "question": "A 7-year-old boy presents with acute cerebellar ataxia following varicella infection 2 weeks prior. MRI shows T2 hyperintensity restricted to the cerebellar hemispheres. CSF demonstrates 15 lymphocytes/mm³, normal glucose, and elevated IgG index. Which of the following autoantibodies is most specific for this condition?", "options": ["Anti-GAD65", "Anti-Hu", "Anti-Yo", "Anti-Tr/DNER", "Anti-mGluR1"], "answer": "D", "answer_index": 3, "explanation": "Post-varicella acute cerebellar ataxia is associated with anti-Tr/DNER (delta/notch-like epidermal growth factor-related receptor) antibodies in a significant proportion of cases. This antibody is highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma but also occurs in post-infectious contexts. Anti-Yo and anti-Hu are associated with gynecological/breast cancers and small cell lung cancer respectively. Anti-mGluR1 is seen in Hodgkin-related ataxia, while anti-GAD65 is associated with stiff-person syndrome.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "The clinical scenario describes acute post-infectious cerebellar ataxia, specifically after varicella infection, with MRI findings limited to the cerebellum and CSF showing lymphocytic pleocytosis and elevated IgG index, suggesting an immune-mediated process.  \n\nAmong the options:  \n\n- **Anti-GAD65** is associated with stiff-person syndrome, cerebellar ataxia, and type 1 diabetes, but not specifically with post-varicella ataxia.  \n- **Anti-Hu** is a paraneoplastic antibody typically linked to small cell lung cancer and encephalomyelitis, not specific to post-varicella cerebellar ataxia.  \n- **Anti-Yo** is a paraneoplastic cerebellar degeneration antibody often associated with ovarian or breast cancer.  \n- **Anti-Tr/DNER** is highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma, but also reported in some post-varicella cerebellar ataxia cases.  \n- **Anti-mGluR1** is associated with paraneoplastic cerebellar ataxia in Hodgkin lymphoma as well.  \n\nHowever, **Anti-Tr/DNER** has been reported in cases of post-varicella acute cerebellar ataxia in children and is the most specific among the listed options for this particular presentation.  \n\nThe answer is D"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-006", "question": "A 42-year-old woman with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) achieves complete morphological remission after induction chemotherapy. Minimal residual disease (MRD) testing by flow cytometry shows 0.01% blasts. Which of the following factors would most strongly indicate proceeding to allogeneic hematopoietic stem cell transplantation in first complete remission rather than continuing with chemotherapy plus a tyrosine kinase inhibitor?", "options": ["Presence of IKZF1 deletion", "Age >40 years", "MRD positivity after consolidation therapy", "White blood cell count >30,000/μL at diagnosis", "Presence of additional cytogenetic abnormalities besides t(9;22)"], "answer": "C", "answer_index": 2, "explanation": "In Ph+ ALL, MRD positivity after consolidation therapy is the strongest predictor of poor outcome with chemotherapy/TKI alone and is a clear indication for allogeneic transplantation in first remission. While age >40, high WBC, IKZF1 deletion, and additional abnormalities are adverse prognostic factors, contemporary TKI-based regimens can overcome many of these. Persistent MRD after intensive therapy indicates resistant disease requiring transplant for cure.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "In Ph+ ALL, the decision to proceed with allogeneic hematopoietic stem cell transplantation (HSCT) in first complete remission (CR1) is strongly guided by **minimal residual disease (MRD) status after initial therapy**, particularly after consolidation.  \n\nCurrent guidelines (e.g., NCCN, ELN) consider **persistent MRD positivity after consolidation therapy** as a high-risk feature that favors allogeneic HSCT in CR1, even in the era of potent tyrosine kinase inhibitors (TKIs).  \n\nWhile the other options (A, B, D, E) may be adverse prognostic factors at diagnosis, MRD response after therapy is the most powerful and dynamic predictor of outcome and is often used to guide transplant decisions.  \n\n**The answer is C**"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-007", "question": "A 65-year-old man with atrial fibrillation on apixaban presents with acute onset of aphasia and right hemiparesis. CT head shows a 3 cm left MCA territory infarct with no hemorrhage. Last apixaban dose was 4 hours ago. NIH Stroke Scale is 18. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator immediately", "Give 4-factor prothrombin complex concentrate followed by tPA", "Perform emergent mechanical thrombectomy without thrombolysis", "Administer andexanet alfa followed by mechanical thrombectomy", "Give idarucizumab empirically followed by mechanical thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "For large vessel occlusion strokes in patients on direct oral anticoagulants (DOACs) with recent dosing, mechanical thrombectomy without thrombolysis is recommended due to the increased risk of hemorrhagic transformation with tPA. Andexanet alfa is a reversal agent for factor Xa inhibitors but is not routinely recommended prior to thrombectomy unless there is life-threatening bleeding. Idarucizumab is for dabigatran reversal. PCC before tPA still carries bleeding risk and delays intervention.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has a large vessel occlusion (left MCA territory) with a high NIHSS and is on apixaban, with the last dose 4 hours ago (peak anticoagulant effect).  \n\n- **A** – tPA is contraindicated due to therapeutic anticoagulation with a direct oral anticoagulant (DOAC) within 48 hours.  \n- **B** – Giving PCC before tPA is not standard; PCC is used for reversal in bleeding, but tPA remains contraindicated here.  \n- **C** – Mechanical thrombectomy without thrombolysis is appropriate for large vessel occlusion in an anticoagulated patient, especially within the thrombectomy window.  \n- **D** – Andexanet alfa is a reversal agent for factor Xa inhibitors like apixaban, but reversal is not required for thrombectomy unless there’s hemorrhage or urgent need for surgery; thrombectomy can proceed without reversal.  \n- **E** – Idarucizumab is for dabigatran, not apixaban.  \n\nThe most appropriate acute intervention is **mechanical thrombectomy without thrombolysis** given the large vessel occlusion, contraindication to tPA, and no need for reversal prior to thrombectomy.  \n\nThe answer is C"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-008", "question": "A 3-year-old child with DiGeorge syndrome (22q11.2 deletion) presents with hypocalcemic seizures. Correction of calcium with intravenous calcium gluconate and calcitriol is initiated. Which of the following immunologic parameters, if present, would be an absolute contraindication to live viral vaccination?", "options": ["CD4+ T cell count <500 cells/μL", "Absent thymic shadow on chest radiograph", "Low but detectable T cell receptor excision circles (TRECs)", "Severely reduced proliferative response to phytohemagglutinin", "Complete absence of CD3+ T cells by flow cytometry"], "answer": "E", "answer_index": 4, "explanation": "Complete absence of CD3+ T cells indicates severe combined immunodeficiency (SCID) phenotype within DiGeorge spectrum, which is an absolute contraindication to live vaccines due to risk of disseminated infection. Reduced proliferative responses (option D) indicate functional impairment but not complete absence. Low TRECs suggest poor thymic output but not necessarily SCID. CD4 count and thymic shadow are not definitive contraindications alone.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "In DiGeorge syndrome, the key immunologic risk for live viral vaccines is the presence of severe T-cell deficiency.  \n\n- **A. CD4+ T cell count <500 cells/μL** – This is low but not an absolute contraindication if some T-cell function exists.  \n- **B. Absent thymic shadow** – Anatomical finding, not a direct measure of immune function.  \n- **C. Low but detectable TRECs** – Indicates some thymic output, not absolute contraindication.  \n- **D. Severely reduced proliferative response to phytohemagglutinin** – Indicates poor T-cell function, but the most absolute contraindication is when there are essentially no T cells.  \n- **E. Complete absence of CD3+ T cells by flow cytometry** – This indicates severe combined immunodeficiency–like presentation in DiGeorge syndrome, which is an absolute contraindication to live vaccines due to the risk of uncontrolled viral infection.  \n\nThe most definitive absolute contraindication is **complete absence of T cells**, as seen in the complete DiGeorge phenotype.  \n\n**The answer is E**"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-009", "question": "A patient with glioblastoma on temozolomide and dexamethasone develops progressive headache, visual changes, and diabetes insipidus. MRI shows thickening and enhancement of the pituitary stalk with loss of the posterior pituitary bright spot. CSF cytology is negative. Which of the following findings would most strongly support a diagnosis of lymphocytic hypophysitis over pituitary metastasis?", "options": ["Presence of anti-pituitary antibodies", "Elevated CSF beta-2 transferrin", "Simultaneous involvement of the pineal gland", "Rapid improvement with high-dose corticosteroids", "Association with other autoimmune endocrine deficiencies"], "answer": "E", "answer_index": 4, "explanation": "Lymphocytic hypophysitis frequently presents with other autoimmune endocrine deficiencies (thyroiditis, adrenalitis, diabetes mellitus type 1), while pituitary metastases typically occur in isolation. Anti-pituitary antibodies have poor sensitivity/specificity. CSF beta-2 transferrin indicates CSF leak. Pineal involvement suggests germinoma. Steroid responsiveness occurs in both conditions but is more dramatic in hypophysitis; however, association with other autoimmune conditions is more specific.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "Lymphocytic hypophysitis is an autoimmune inflammation of the pituitary, often presenting with mass effect and endocrine dysfunction, and is typically responsive to corticosteroids. Pituitary metastasis, while possible in glioblastoma, would not be expected to improve rapidly with steroids alone.  \n\n- **A** (anti-pituitary antibodies) is not routinely used clinically and lacks sufficient sensitivity/specificity.  \n- **B** (elevated CSF beta-2 transferrin) indicates CSF leak, not relevant here.  \n- **C** (pineal involvement) is nonspecific and not typical for hypophysitis.  \n- **D** (rapid improvement with high-dose corticosteroids) is characteristic of inflammatory conditions like lymphocytic hypophysitis but not metastasis.  \n- **E** (other autoimmune endocrine deficiencies) can be seen but is not as immediately supportive as a dramatic treatment response.  \n\nThe most **strongly supportive** finding in the clinical setting described is a rapid response to corticosteroids, which would be unusual for metastasis.  \n\nThe answer is D"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-010", "question": "A neonate born at 32 weeks gestation develops necrotizing enterocolitis (NEC) on day 10 of life. During laparotomy, approximately 40% of the small bowel appears necrotic. Which of the following intraoperative findings would mandate creation of a high jejunostomy rather than primary anastomosis?", "options": ["Involvement of the ileocecal valve", "Necrosis extending to within 5 cm of the ligament of Treitz", "Presence of pneumatosis intestinalis in the remaining bowel", "Concurrent isolated perforation of the gastric fundus", "Development of abdominal compartment syndrome during surgery"], "answer": "B", "answer_index": 1, "explanation": "Necrosis extending to within 5 cm of the ligament of Treitz indicates near-total small bowel loss, requiring high jejunostomy to preserve the maximal possible length of viable bowel for future adaptation and prevent anastomotic leakage in compromised tissue. Ileocecal valve involvement is important for absorption but doesn't dictate anastomosis vs ostomy. Pneumatosis may be present in non-necrotic bowel. Gastric perforation is managed separately. Abdominal compartment syndrome may require temporary closure but not necessarily jejunostomy.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "In necrotizing enterocolitis requiring surgery, the decision to perform a primary anastomosis versus creating an enterostomy depends on factors such as the viability of the remaining bowel, hemodynamic stability, and the location of the disease.  \n\nIf necrosis extends very proximally, leaving a very short segment of viable proximal jejunum, a primary anastomosis may be unsafe due to concerns about anastomotic healing and high output from a proximal stoma if created. A high jejunostomy (rather than anastomosis) would be considered when the remaining proximal jejunum is extremely short — typically within a few centimeters of the ligament of Treitz — because anastomosing such a short segment to distal bowel under conditions of NEC and inflammation risks breakdown and makes nutritional management difficult.  \n\nAmong the options:  \n- **A. Involvement of the ileocecal valve** → This is distal, not a reason for high jejunostomy specifically.  \n- **B. Necrosis extending to within 5 cm of the ligament of Treitz** → This leaves very little viable proximal jejunum, making primary anastomosis risky; a high jejunostomy would be mandated.  \n- **C. Presence of pneumatosis in remaining bowel** → Indicates ongoing disease but not an absolute contraindication to anastomosis if bowel is viable.  \n- **D. Concurrent isolated perforation of gastric fundus** → Unrelated to decision about small bowel anastomosis vs stoma.  \n- **E. Development of abdominal compartment syndrome** → Would require leaving abdomen open, but not specifically mandate jejunostomy over anastomosis.  \n\nThe best answer is **B**.  \n\nThe answer is (B)"}]